Bessemer Venture Partners

Bessemer Venture Partners, established in 1911, is a prominent venture capital firm headquartered in Redwood City, California, with a global presence. The firm invests in early-stage to growth-stage companies across various sectors, including software, TMT, healthcare, fintech, and consumer products. With a portfolio boasting successful companies like Pinterest, Shopify, Twilio, and Yelp, Bessemer Venture Partners has a proven track record in helping entrepreneurs build enduring companies. The firm manages multiple funds, totaling over $4 billion in assets, and provides support to founders from seed stage through to growth, fostering long-term relationships with its portfolio companies.

Anurag Begwani

Vice President

Thomas Berger

Partner

Charles Birnbaum

Partner

Sam Bondy

Investor

Sara Byrne

Partner and CFO

Aparna Chaganty

Investor

Justina Chung

Vice President

David Cowan

Partner

Brian Cramer

Operating Partner

Mary D'Onofrio

Partner

Byron Deeter

Partner

Sameer Dholakia

Partner

John Drake

Investor

Mike Droesch

Vice President

Jeff Epstein

Operating Partner

Brian Feinstein

Partner

Adam Ferrara

Partner

Alex Ferrara

Partner

Adam Fisher

Partner

Andrew Geisse

Operating Partner

Talia Goldberg

Partner

Bob Goodman

Partner

Alexa Grabelle

Investor

Sandy Grippo

COO and Partner

Sofia Guerra

Vice President, Cambridge office

Felda Hardymon

Partner

Tess Hatch

Partner

Andrew Hedin

Partner

Nithin Kaimal

COO

Eric Kaplan

Vice President and Investor

Amit Karp

Partner

Hannah Kim

Vice President

Stephen Kraus

Partner

Ethan Kurzweil

Partner

Lindsey Li

Vice President

Grace Ma

Investor

Maha Malik

Investor

Bhavik Nagda

Investor

Aditya Nidmarti

Investor

Bob O'Neil

Venture Partner

Darsh Patel

Investor

Anant Vidur Puri

Partner

Caty Rea

Vice President

Elliott Robinson

Partner and Co-Founder of the Growth Investment Practice

Raj Sabhlok

Operating Partner

Aia Sarycheva

Vice President

Jason Scheller

Investor

Yael Schiff

Vice President

Andrew Schmitt

Investor

David Selverian

Investor

Madeline Shue

Investor

Smith, Scott

Operating Partner

Robert Stavis

Partner

Ariel Sterman

Partner

Nancy Straface

Director of IT and Managed Services

Mayo Stuntz

Operating Partner

Alexandra Sukin

Vice President

Vatsalya Tandon

Investor

Janice Teng

Vice President

Katherine Walker

Vice President

Christopher Wan

Vice President

Bryan Wu

Partner

Alex Yuditski

Investor

Past deals in Dietary Supplements

Boldfit

Series A in 2024
Boldfit is a direct-to-consumer brand that specializes in fitness products, offering a range of gym equipment and nutritional supplements to support your fitness journey. Its fitness product categories include resistance bands, yoga mats, bottles and shakers, and home gym accessories. Bold Fit also provides proteins, recovery, and intra supplements, as well as daily essentials, omega 3, detox, bone, and joint health nutrition supplements.

Oshi Health

Series C in 2024
Oshi Health is a virtual-first gastroenterology clinic focused on diagnosing, treating, and remotely monitoring digestive conditions. The company employs an integrated care team comprising gastroenterologists, GI-specialized nurse practitioners, registered dietitians, behavioral psychologists, and health coaches. This multidisciplinary approach allows patients to identify the root causes of their symptoms and develop personalized care plans that incorporate medication, dietary changes, and gut-brain behavioral therapy. Oshi Health aims to enhance access to digestive health care, improve patient experiences, and achieve better clinical outcomes, ultimately helping patients gain lasting control over their symptoms and improve their quality of life.

Oshi Health

Series B in 2023
Oshi Health is a virtual-first gastroenterology clinic focused on diagnosing, treating, and remotely monitoring digestive conditions. The company employs an integrated care team comprising gastroenterologists, GI-specialized nurse practitioners, registered dietitians, behavioral psychologists, and health coaches. This multidisciplinary approach allows patients to identify the root causes of their symptoms and develop personalized care plans that incorporate medication, dietary changes, and gut-brain behavioral therapy. Oshi Health aims to enhance access to digestive health care, improve patient experiences, and achieve better clinical outcomes, ultimately helping patients gain lasting control over their symptoms and improve their quality of life.

Oshi Health

Series A in 2021
Oshi Health is a virtual-first gastroenterology clinic focused on diagnosing, treating, and remotely monitoring digestive conditions. The company employs an integrated care team comprising gastroenterologists, GI-specialized nurse practitioners, registered dietitians, behavioral psychologists, and health coaches. This multidisciplinary approach allows patients to identify the root causes of their symptoms and develop personalized care plans that incorporate medication, dietary changes, and gut-brain behavioral therapy. Oshi Health aims to enhance access to digestive health care, improve patient experiences, and achieve better clinical outcomes, ultimately helping patients gain lasting control over their symptoms and improve their quality of life.

Spero Foods

Series A in 2021
Spero Foods, Inc. is a company that specializes in producing and selling alternative dairy products, focusing primarily on cream cheese. Founded in 2016 and headquartered in Oakland, California, Spero employs innovative food science and process engineering to create mainstream plant-based dairy alternatives. The company aims to provide healthy food options for all individuals, positioning itself as a disruptor in the traditional dairy market. Spero Foods' products are available through various channels, including wholesalers, retail stores, and online platforms across the United States. The company has gained recognition for its innovative approach and has received awards from notable organizations such as Fast Company, NEXTY, and The Food Network. Its products can be found in over 3,500 authorized locations, including major retailers like Kroger, Whole Foods, Publix, and Sprouts.

Allena Pharmaceuticals

Post in 2017
Allena Pharmaceuticals, Inc. is a late-stage clinical biopharmaceutical company based in Newton, Massachusetts, focused on the development and commercialization of innovative oral enzyme therapeutics for rare and severe metabolic and kidney disorders. Founded in 2011, the company’s lead product candidate, reloxaliase, is currently undergoing a pivotal Phase 3 clinical program aimed at treating enteric hyperoxaluria, a condition characterized by elevated urinary oxalate levels that can lead to kidney stones and chronic kidney disease. Additionally, Allena is developing ALLN-346, a novel enzyme intended to address hyperuricemia in patients with moderate to severe chronic kidney diseases. By targeting metabolic disorders associated with the accumulation of harmful metabolites, Allena Pharmaceuticals aims to provide effective treatments for patients facing serious health challenges.

Allena Pharmaceuticals

Series B in 2014
Allena Pharmaceuticals, Inc. is a late-stage clinical biopharmaceutical company based in Newton, Massachusetts, focused on the development and commercialization of innovative oral enzyme therapeutics for rare and severe metabolic and kidney disorders. Founded in 2011, the company’s lead product candidate, reloxaliase, is currently undergoing a pivotal Phase 3 clinical program aimed at treating enteric hyperoxaluria, a condition characterized by elevated urinary oxalate levels that can lead to kidney stones and chronic kidney disease. Additionally, Allena is developing ALLN-346, a novel enzyme intended to address hyperuricemia in patients with moderate to severe chronic kidney diseases. By targeting metabolic disorders associated with the accumulation of harmful metabolites, Allena Pharmaceuticals aims to provide effective treatments for patients facing serious health challenges.

Allena Pharmaceuticals

Series A in 2011
Allena Pharmaceuticals, Inc. is a late-stage clinical biopharmaceutical company based in Newton, Massachusetts, focused on the development and commercialization of innovative oral enzyme therapeutics for rare and severe metabolic and kidney disorders. Founded in 2011, the company’s lead product candidate, reloxaliase, is currently undergoing a pivotal Phase 3 clinical program aimed at treating enteric hyperoxaluria, a condition characterized by elevated urinary oxalate levels that can lead to kidney stones and chronic kidney disease. Additionally, Allena is developing ALLN-346, a novel enzyme intended to address hyperuricemia in patients with moderate to severe chronic kidney diseases. By targeting metabolic disorders associated with the accumulation of harmful metabolites, Allena Pharmaceuticals aims to provide effective treatments for patients facing serious health challenges.

Mothernature.com

Series B in 1999
Mothernature.com is an online retail store based in Doargo, Florida, specializing in vitamins, minerals, supplements, and other products related to natural and healthy living. The company aims to be a leading destination for consumers seeking earth-friendly products by combining an extensive range of offerings with informative content. In addition to its product selection, Mothernature.com provides free health information contributed by a panel of medical experts, enhancing its role as a resource for health-conscious individuals. Through this innovative approach, the company seeks to establish itself as a trusted source for natural wellness solutions.

Mothernature.com

Series A in 1998
Mothernature.com is an online retail store based in Doargo, Florida, specializing in vitamins, minerals, supplements, and other products related to natural and healthy living. The company aims to be a leading destination for consumers seeking earth-friendly products by combining an extensive range of offerings with informative content. In addition to its product selection, Mothernature.com provides free health information contributed by a panel of medical experts, enhancing its role as a resource for health-conscious individuals. Through this innovative approach, the company seeks to establish itself as a trusted source for natural wellness solutions.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.